Cosmo Pharmaceuticals NV

Cosmo Pharmaceuticals NV is a Dublin‑based specialty pharma focused on gastroenterology, dermatology, and healthtech, offering AI‑driven GI Genius, approved ulcerative colitis drugs Lialda/Mezavant, and a pipeline of AI diagnostics and androgen‑targeted agents in trials.

Headquarters: Switzerland (CHE)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical Practices

Employees: 332
HQ: Dublin

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
COPN	Cosmo Pharmaceuticals NV Cap: 1.7B \| P/E: 32.6	EQUITY	EBS	CHF	NL0011832936	Active	📈